Medical News Today: Missed periods and ovarian cancer
Most causes of missed or irregular periods are not serious. However, less commonly, a missed period can be a sign of ovarian cancer. Early detection and treatment of this type of cancer can improve a person ’s outlook. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 12, 2018 Category: Consumer Health News Tags: Ovarian Cancer Source Type: news

Breast Cancer Gene Also Linked To Prostate And Pancreatic Cancers
BOSTON (CBS) – Alex Fitzpatrick went from Hollywood screenwriter to Massachusetts restaurant owner so she and her husband could spend more time with her children. When she recently found out her risk of getting breast cancer was as high as 80%, all she could think of was her three boys. “I do want to make sure that I’m the one telling them what to wear on their wedding day and watch them go to college,” she said. Alex has one of the BRCA gene mutations. She got tested when an aunt was recently diagnosed with an aggressive form of breast cancer. “I was blindsided to be honest,” she remem...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 10, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Watch Listen Angelina Jolie Breast Cancer Dr. Mallika Marshall Mass General Hospital Source Type: news

Talcum powder may be associated with respiratory illness and possibly ovarian cancer, Health Canada warns
Don't inhale talcum powder and keep it away from children's faces and female genitals, Canada's health and environment agencies advised on Wednesday. (Source: CBC | Health)
Source: CBC | Health - December 5, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

Effect of religiosity/spirituality on ovarian cancer diagnosis in African American women
(Mary Ann Liebert, Inc./Genetic Engineering News) An examination of data from a multi-center case-control study of ovarian cancer in African American women found that women who reported higher levels of religiosity/spirituality had increased odds of stage III-IV ovarian cancer at diagnosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2018 Category: International Medicine & Public Health Source Type: news

The First Baby Has Been Born After a Uterus Transplant From a Deceased Donor
The world’s first baby born by a uterus transplant from a deceased donor is healthy and nearing her first birthday, according to a new case study published Tuesday in the Lancet. Uterus transplants have become more common in recent years, resulting in 11 live births around the world. But all of the other successful deliveries so far have been made possible by living donors — often women who opt to donate their uterus to a close friend or family member without one. The birth resulting from the case detailed in the Lancet, which took place at Brazil’s Hospital das Clínicas last December, is both the first...
Source: TIME: Health - December 4, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized fertility healthytime Source Type: news

$5.1B deal: GSK buying ovarian cancer drug developer
In a major move to boost its oncology product pipeline, GlaxoSmithKline entered into a definitive agreement Monday to acquire Boston-area biopharmaceutical company Tesaro for $5.1 billion. Tesaro (NASDAQ: TSRO) of Waltham, Mass., markets the ovarian cancer therapy Zejula, which is approved in the United States and Europe. The company is also conducting clinical trials that if successful could lead to an expanded use of the drug, as a monotherapy and in combination with other ovaria n cancer treatments. “The… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 4, 2018 Category: Biotechnology Authors: John George Source Type: news

Most ovarian cysts may not need surveillance
Women with simple ovarian cysts detected by ultrasound didn ’t develop ovarian cancer at elevated rates over the next three years, adding to evidence that these cysts aren’t dangerous. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - December 4, 2018 Category: Consumer Health News Source Type: news

Novel Blood Test a Potential'Game Changer' in Ovarian Cancer Novel Blood Test a Potential'Game Changer' in Ovarian Cancer
Novel blood test picks up ovarian cancer at all stages of disease, including early stage, opening the door to much earlier detection and optimally increasing survival odds.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Charity aims to develop first screening tool for ovarian cancer
A charity is encouraging nurses to support its appeal to develop the world ’s first screening tool for ovarian cancer. (Source: Nursing Times)
Source: Nursing Times - November 27, 2018 Category: Nursing Source Type: news

Does Ovarian Cancer Screening Actually Improve Survival?
A screening study that began more than 30 years ago looked at ultrasound screening for at-risk women for ovarian cancer and its effects on disease-specific survival. (Source: CancerNetwork)
Source: CancerNetwork - November 27, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Medical News Today: Ovarian cancer statistics
Knowing the statistics on ovarian cancer can help a person better understand the condition. However, it is important to remember that everyone has a different experience with cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 26, 2018 Category: Consumer Health News Tags: Ovarian Cancer Source Type: news

Cancer survivor, 25, to have a pioneering operation to REVERSE her early menopause
Adele Stevens, from Reading, is said to be the 'second patient' to undergo ovarian cryopreservation to restore fertility, after chemotherapy for bone cancer gave her the menopause 20 years early. (Source: the Mail online | Health)
Source: the Mail online | Health - November 26, 2018 Category: Consumer Health News Source Type: news

Medical News Today: New blood test can detect ovarian cancer in its early stages
Ovarian cancer is rarely detected in its early stages, which makes treatment less effective. A new blood test, however, may become a game-changer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 23, 2018 Category: Consumer Health News Tags: Ovarian Cancer Source Type: news

Neoadjuvant Chemotherapy or Upfront Surgery in Advanced Ovarian Cancer?
A pooled analysis of two randomized trials found that neoadjuvant chemotherapy and upfront debulking surgery yield similar outcomes in patients with advanced tubo-ovarian cancer, except in some settings. (Source: CancerNetwork)
Source: CancerNetwork - November 19, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Merck KGaA, Pfizer drug fails late-stage cancer trial
Merck KGaA and Pfizer announced that the cancer immunotherapy avelumab did not meet the primary endpoints of a phase 3 ovarian cancer trial. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 19, 2018 Category: Pharmaceuticals Source Type: news

Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
DARMSTADT, Germany and NEW YORK, November 19, 2018 -- (Healthcare Sales & Marketing Network) -- Merck KGaA, Darmstadt, Germany, and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combi... Biopharmaceuticals, Oncology Merck KGaA, Pfizer, avelumab, ovarian cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 19, 2018 Category: Pharmaceuticals Source Type: news

Merck and Pfizer provide update on avelumab in platinum-resistant/refractory ovarian cancer
Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the prespecified primary endpoints of overall survival (OS) or progression-free survival (PFS) in patients with platinum-resistant or -refractory ovarian cancer. (Source: World Pharma News)
Source: World Pharma News - November 19, 2018 Category: Pharmaceuticals Tags: Featured Merck Group Business and Industry Source Type: news

New blood test detects early stage ovarian cancer
(University of Adelaide) Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer -- a disease which kills over 1000 Australian women and 150,000 globally each year. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 19, 2018 Category: Cancer & Oncology Source Type: news

New imaging method could boost ovarian cancer detection
A new imaging technique based on photoacoustic imaging could help clinicians...Read more on AuntMinnie.comRelated Reading: Ultrasound helps predict ovarian cancer risk Cinematic rendering enhances ovarian cancer evaluation Calif. governor vetoes breast, ovarian genetic testing bill USPSTF again nixes screening for ovarian cancer New imaging method helps detect ovarian tumors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 16, 2018 Category: Radiology Source Type: news

Living With Cancer: Tackling Cancer Anxiety
No matter how long I deal with periodic blood tests, abdominal CTs and mammograms, they always trigger a huge wave of ‘ scanxiety. ’ (Source: NYT Health)
Source: NYT Health - November 15, 2018 Category: Consumer Health News Authors: SUSAN GUBAR Tags: Ovarian Cancer Mammography Mastectomy Source Type: news

'Hopeful technology' could change detection, diagnosis of deadly ovarian cancer
(Washington University in St. Louis) Ovarian cancer claims the lives of more than 14,000 women in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University has found an innovative way to use sound and light to diagnose ovarian tumors, which may lead to a promising new diagnostic imaging technique to improve current standard of care. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 14, 2018 Category: Cancer & Oncology Source Type: news

Most simple ovarian cysts require no treatment, surveillance
Simple ovarian cysts have almost zero percent chance of developing into cancer, according to a new study, and don't require surgery or monitoring. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 12, 2018 Category: Consumer Health News Source Type: news

Simple Ovarian Cysts on Ultrasound Need No Further Monitoring Simple Ovarian Cysts on Ultrasound Need No Further Monitoring
Simple ovarian cysts discovered on ultrasound are not associated with an increased risk for ovarian cancer and do not need further follow-up imaging, say researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Ultrasound helps predict ovarian cancer risk
Ultrasound can help characterize ovarian masses -- specifically simple cysts...Read more on AuntMinnie.comRelated Reading: Cinematic rendering enhances ovarian cancer evaluation Calif. governor vetoes breast, ovarian genetic testing bill USPSTF again nixes screening for ovarian cancer PET/MRI outclasses MRI alone for pelvic cancer recurrence New imaging method helps detect ovarian tumors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 12, 2018 Category: Radiology Source Type: news

Simple Ovarian Cysts Hold No Cancer Risk
(MedPage Today) -- Malignancy extremely rare, don't need surveillance (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 12, 2018 Category: Hematology Source Type: news

NHS patients set to have access to breakthrough drug
Thousands of NHS patients with a genetic type of ovarian cancer will soon have access to a new treatment, hailed as a wonder drug, that slashes the risk of death from the condition by 70 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - November 10, 2018 Category: Consumer Health News Source Type: news

Many Women Have Not Heard of Ovarian Cancer Before Dx
Nine in 10 women experience multiple symptoms prediagnosis; eight in 10 of them consult a doctor (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 10, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Institutional, Source Type: news

Many Women Have Not Heard of Ovarian Cancer Before Dx
FRIDAY, Nov. 9, 2018 -- Many women are not knowledgeable about ovarian cancer before diagnosis despite most women experiencing prediagnosis symptoms, according to a report published online Oct. 18 by the World Ovarian Cancer Coalition. Researchers... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 9, 2018 Category: Pharmaceuticals Source Type: news

Cancer specialists slam decision by health watchdog to NOT recommend a drug for ovarian cancer
Nice has ruled against expanding the use of groundbreaking drug olaparib, developed by British scientists. Charity cancers call it a 'bitter blow' to thousands who could miss out. (Source: the Mail online | Health)
Source: the Mail online | Health - November 9, 2018 Category: Consumer Health News Source Type: news

NICE rejects ovarian cancer maintenance drug
Olaparib tablets are deemed too expensive Related items fromOnMedica Fertility treatment does not appear to raise serious cancer risk Searching for a blood test to monitor ovarian cancer Ovarian cancer drug may help stall breast cancer Screen all women for breast/ovarian cancer genetic faults, say researchers An intelligent knife can tell ovarian cancer and healthy tissue apart (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 9, 2018 Category: UK Health Source Type: news

Should You Take Aspirin Every Day? Here ’s What the Science Says
Aspirin is best known as an over-the-counter painkiller. But acetylsalicylic acid, as it’s called chemically, has many other health benefits, as well as side effects, in the body that have only become clear in recent years. Here’s what the latest science says about the health benefits and side effects of aspirin, as well as which conditions it may treat and those it doesn’t appear to improve. (If you are taking aspirin for any reason other than for periodic pain relief, it’s best to consult with your doctor to confirm whether the benefits outweigh the risks in your particular case.) How aspirin affe...
Source: TIME: Health - November 8, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthytime Source Type: news

Ovarian Ca Risk Reduced with Postmenopausal Statins
(MedPage Today) -- All histologic types of ovarian cancer risk lowered in statin versus non-statin users (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 6, 2018 Category: Cardiology Source Type: news

Role of PARP Inhibitors in BRCA-Related Malignancies Role of PARP Inhibitors in BRCA-Related Malignancies
Review the pharmacology of PARP inhibitors and their use in BRCA-mutated malignancies including breast, ovarian, fallopian tube, and primary peritoneal cancers.U.S. Pharmacist (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2018 Category: Consumer Health News Tags: Pharmacist Journal Article Source Type: news

Sex hormone blocker increases likelihood of pregnancy in breast cancer patients
The sex hormone blocker, goserelin, protects the ovaries from breast cancer chemotherapy, improving the likelihood of future pregnancy, according to research published in theJournal of the National Cancer Institute. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 31, 2018 Category: Endocrinology Source Type: news

University of Arizona researchers make next move in the fight against ovarian cancer
(University of Arizona College of Engineering) Jennifer Barton, engineering professor and director of the University of Arizona's BIO5 Institute, is using an $863,000 grant from the United States Army to test a minimally invasive ovarian cancer screening device in vivo for the first time. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 31, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: Does baby powder cause cancer? What to know
Baby powder manufacturers have recently faced lawsuits that their product, a type of talc, may cause ovarian cancer. Learn about the claims and research here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 30, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Novel technique can potentially improve success of ovarian cancer treatment, study reveals
This study is the first to investigate the impact of establishing a healthy blood supply to the tumour prior to treatment in mice models with an advanced stage of ovarian cancer. The researcher found this novel technique provides a clear pathway for treatment improving its success. This is opposite to a current approach that involves destroying the blood supply in an effort to starve the tumour. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 30, 2018 Category: Cancer & Oncology Source Type: news

Breast-Feeding Is Good for the Mother, and Not Just the Baby
Women who breast-feed are less likely to develop breast cancer, ovarian cancer, Type 2 diabetes and rheumatoid arthritis and may have improved cardiovascular health. (Source: NYT Health)
Source: NYT Health - October 26, 2018 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Breast Cancer Breastfeeding Women and Girls Ovarian Cancer Pregnancy and Childbirth Diabetes Babies and Infants Parenting Infant Formulas Source Type: news

TV doctor Ellen Pompeo slammed by real doctors for giving inaccurate advice about ovarian cancer
The actress, who played a doctor on Grey's Anatomy, went off-script on The Ellen Show this week, to tell viewers that she'd heard 'all it takes is a simple ultrasound' to detect the disease. (Source: the Mail online | Health)
Source: the Mail online | Health - October 25, 2018 Category: Consumer Health News Source Type: news

Expect Boston Scientific to Keep Rounding Out Its Portfolio with M & amp;A
 Boston Scientific has been on quite the shopping spree in 2018. The Marlborough, MA-based company has announced eight acquisitions since the beginning of the year, plus a hefty investment in Millipede, which is likely to lead to an acquisition within the next year or so. Naturally, the company's aggressive M&A strategy has attracted attention from industry analysts who are eager to see if this spree will continue in 2019. During the company's third-quarter earnings call on Thursday, CFO Daniel Brennan said Boston Scientific still has a "tremendous amount" of financial flexibility. Loo...
Source: MDDI - October 25, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Maintenance Olaparib Yields Impressive Results in Advanced Ovarian Cancer
Researchers tested whether 2 years of maintenance therapy with olaparib would improve outcomes in advanced ovarian cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - October 22, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

AstraZeneca sees strong ovarian cancer trial results
AstraZeneca ’s Lynparza greatly reduced the risk of ovarian cancer worsening in a phase III trial, helping the drugmaker take the lead against two U.S. rivals in the same class. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 22, 2018 Category: Pharmaceuticals Source Type: news

Low-dose aspirin may reduce ovarian cancer risk
Taking a baby aspirin may reduce the risk of ovarian cancer but using other types of anti-inflammatory drugs long-term has the opposite effect, a new study found.   The study of 205,498 women published in the journal JAMA Oncology found that regular users of low-dose aspirin appear to have a reduced risk of developing ovarian cancer, while users of other painkillers in high doses, particularly non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs), have a higher risk.  “There is growing evidence… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 22, 2018 Category: Pharmaceuticals Authors: Anne Stych Source Type: news

Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer
(European Society for Medical Oncology) Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free survival compared to tamoxifen in premenopausal women with hormone receptor positive (HR+) early breast cancer, according to results reported at ESMO 2018 Congress in Munich. It is the first study to assess this specific combination in premenopausal breast cancer and adds to previous observations with zoledronic acid and anastrozole in premenopausal women receiving ovarian suppression. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 22, 2018 Category: Cancer & Oncology Source Type: news

Breakthrough drug slashes chances of ovarian cancer returning
A breakthrough treatment for ovarian cancer slashes the chance of it returning, a study has found. Two thirds of patients given the drug during a trial had not relapsed within three years. (Source: the Mail online | Health)
Source: the Mail online | Health - October 22, 2018 Category: Consumer Health News Source Type: news

Practice-Changing PARP Inhibitor Study in Ovarian Cancer
(MedPage Today) -- " Unprecedented " increase in PFS with upfront olaparib maintenance (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 21, 2018 Category: Hematology Source Type: news

' Outstanding' Ovarian Cancer PFS With Olaparib Maintenance'Outstanding' Ovarian Cancer PFS With Olaparib Maintenance
Patients with newly diagnosed advanced ovarian cancer have a marked increase in progression-free survival with maintenance olaparib after successful first-line chemotherapy, phase 3 study data indicates.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 21, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

AstraZeneca's Lynparza shown to put brakes on ovarian cancer
An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S. rivals in the same class. (Source: Reuters: Health)
Source: Reuters: Health - October 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Can Low-Dose Aspirin Lower Ovarian Cancer Risk?
Regular users of low-dose aspirin appear to have a reduced risk of developing ovarian cancer, according to a new study. (Source: CancerNetwork)
Source: CancerNetwork - October 20, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Why some cancers affect only young women
(Universit é de Gen è ve) Among several forms of pancreatic cancer, one of them affects specifically women, often young, even though the pancreas is an organ with little exposure to sex hormones. This pancreatic cancer, known as 'mucinous cyst,' has strange similarities with another mucinous cancer, affecting the ovaries. By conducting large-scale analyses of genomic data, researchers at the University of Geneva and at the University Hospitals of Geneva have provided an answer: both tumors originate from embryonic germ cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 19, 2018 Category: Cancer & Oncology Source Type: news